Showing 871-880 of 10817 results for "".
Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Effective Speechmaking for Physicians
https://practicaldermatology.com/topics/practice-management/effective-speechmaking-for-physicians/21666/Dermatologists can utilize these tips to exude confidence, make a good first impression, and connect with any audience.Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.Innovation Station
https://practicaldermatology.com/topics/practice-management/innovation-station/20751/CES 2017 unveils a host of digital health tools.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.Are You Paying Too Much In Taxes?
https://practicaldermatology.com/topics/practice-management/are-you-paying-too-much-in-taxes/23054/How a common tax mistake can cost you thousands.Key Tax Mistakes to Avoid
https://practicaldermatology.com/topics/practice-management/key-tax-mistakes-to-avoid/21260/How a common tax mistake could be costing you thousands annually.Keloids: To Cut or Not to Cut
https://practicaldermatology.com/topics/skin-cancer-photoprotection/keloids-to-cut-or-not-to-cut/19987/When treating keloids, ask patients what they want to achieve. Are they hoping to decrease itch or pain? Do they want to flatten or soften the appearance of a keloid? Hilary Baldwin, MD reviews her approach to deciding whether to remove a keloid surgically as well as other treatment options. Plus, sDupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sImproving Therapeutic Outcomes for Acne Patients Using Topical Medications
https://practicaldermatology.com/topics/practice-management/improving-therapeutic-outcomes-for-acne-patients-using-topical-medications/20403/Four pearls for making today's acne therapies work for your patients.